On December 7, 2020, Kenota Health announced it has raised $11 million in financing to support its point-of-care allergy testing. Kenota’s initial seed financing round of $2 million was followed by a $9 million Series A led by Draper Associates, totaling $11 million in funding. The funding will be used to provide rapid and reliable allergy testing and will enable physicians to test and treat more patients in a single clinic visit.
Kenota Health is a Waterloo based medical technology company focused on improving healthcare through data and testing. Kenota is focused on providing a new approach to allergy testing which takes less than 30 minutes to test for a patient’s allergic sensitizations.
Osler, Hoskin & Harcourt LLP advised Kenota Health with a team consisting of Chad Bayne, Gary Marshall and Theresa Donkor (Emerging and High Growth Companies).